Jefferies Assumes Oncology Institute at Buy, Announces Price Target of $2.5
Portfolio Pulse from Benzinga Newsdesk
Jefferies analyst Jack Slevin has initiated coverage on Oncology Institute (NASDAQ:TOI) with a Buy rating and set a price target of $2.5.

February 26, 2024 | 11:00 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Jefferies analyst Jack Slevin has given Oncology Institute a Buy rating with a price target of $2.5.
The initiation of coverage by a reputable analyst with a Buy rating and a specific price target usually signals a positive outlook on the stock, suggesting potential upside. This can lead to increased investor interest and potentially drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100